reports
GrowGeneration to Participate in IgniteIt Cannabis Market Spotlight on...
GrowGeneration to Participate in IgniteIt Cannabis Market Spotlight on October 8, 2025 DENVER, Oct. 01, 2025 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGen” or the “Company”), the nation’s largest specialty hydroponic and organic gardening retailer, today announced that members of management will participate in the IgniteIt “Cannabis Market Spotlight: California” event, which is being held October 8, 2025 in Anaheim, California. Jason Holland, GrowGen’s Vice President of Product Innovation & Commercial Solutions, will participate in a panel discussion titled “Efficienc...
Daxor Unveils New FDA-Cleared BVA Analyzer Amid Strong Market Demand a...
Daxor Unveils New FDA-Cleared BVA Analyzer Amid Strong Market Demand and Pivotal Clinical Data at HFSA Three Studies Validate BVA-Guided Care Significantly Cuts Hospital Readmissions and Boosts Survival in High-Cost Heart Failure Segments OAK RIDGE, TN, Sept. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces significant commercial momentum and clinical validation following the Heart Failure Society of America (HFSA) Annual Scientific Meeting. The company’s successful debut of its newly FDA-cleared, next-generation BVA a...
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(...
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) CHASKA, Minn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that on September 22, 2025, the Lifecore compensation committee approved the grant under Lifecore’s Equity Inducement Plan, as amended (the “Inducement Plan”) of a restricted stock unit (“RSU”) award with respect to 15,000 shares of its common stock and stock options for 30,000 shares of common stock to a newly hired em...
Daxor Corporation Unveils Breakthrough Next-Gen BVA Analyzer at HFSA A...
Daxor Corporation Unveils Breakthrough Next-Gen BVA Analyzer at HFSA Annual Scientific Meeting Additional New Clinical Data To Be Presented Driving a New Standard of Care in Volume Measurement OAK RIDGE, Tenn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces it will exhibit at the Heart Failure Society of America (HFSA) Annual Scientific Meeting in Minneapolis, Minnesota, from September 26-29, 2025. The company will debut its newly FDA-cleared, next-generation blood volume analyzer (BVA), signaling a ...
GrowGeneration to Present at the H.C. Wainwright 27th Annual Global In...
GrowGeneration to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025 DENVER, Sept. 08, 2025 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGen” or the “Company”), the nation’s largest specialty hydroponic and organic gardening retailer, today announced that Darren Lampert, GrowGen’s Chief Executive Officer and Co-Founder, will present virtually at the H.C. Wainwright 27th Annual Global Investment Conference, which is being held September 8-10, 2025 in New York City. Mr. Lampert’s presentation is now available on demand in the In...
Lifecore Biomedical to Participate at 24th Annual Contract Pharma Cont...
Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference CHASKA, Minn., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 24th Annual Contract Pharma Contracting and Outsourcing Conference. Recognized as one of the top annual events for pharmaceutical outsourcing and contract manufacturing, the Contract Pharma conference will take place September 18-19, 2025, in New Brun...
Daxor's Blood Volume Analysis Validated for COVID and Sepsis Patients ...
Daxor's Blood Volume Analysis Validated for COVID and Sepsis Patients in New Peer-Reviewed Pilot Study Published in the Journal of Critical Care Study Demonstrates That Clinical Assessments of Fluid Status Are Often Inaccurate, Highlighting the Urgent Need for BVA and Other More Reliable Tools in Landmark Pilot Study Oak Ridge, TN, Sept. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: DXR), the global leader in blood volume measurement technology, today highlighted the significant findings of a new pilot study published in the Journal of Critical Care. Co-authored by leading intensive care expert...
Daxor Corporation to Present at the H.C. Wainwright 27th Annual Global...
Daxor Corporation to Present at the H.C. Wainwright 27th Annual Global Investment Conference Oak Ridge, TN, Sept. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh will present at the H.C. Wainwright 27th Annual Global Investment Conference being held on September 8-10, 2025 in New York City at the Lotte New York Palace Hotel. The presentation will be available on-demand beginning Friday, September 5 at 7:00 a.m. ET. Investors who wish to listen to the Company’s presentation can...
Lifecore Biomedical to Participate in Upcoming Investor Conferences
Lifecore Biomedical to Participate in Upcoming Investor Conferences CHASKA, Minn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in multiple upcoming investor conferences. Details regarding Lifecore’s participation are as follows: Morgan Stanley 23rd Annual Global Healthcare ConferenceDetails: Lifecore management will participate in a fireside chat and in investor meetingsConference Dates: September 8-10, 2025Fireside...
Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Hal...
Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter Oak Ridge, TN, Sept. 02, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial update in a Letter to Shareholders from CEO and President Michael Feldschuh. Dear Valued Shareholders, "Patience, persistence and perspiration make an unbeatable combination for success." – Napoleon Hill. This timeless wisdom resonates deeply with the journey we've undertaken at Daxor Corporation, and it p...
- Dave Nicoski
- Ross LaDuke
PBF PBF ENERGY INC. CLASS A
LEN LENNAR CORPORATION CLASS A
GPRE GREEN PLAINS INC.
GBCI GLACIER BANCORP INC.
FFIC FLUSHING FINANCIAL CORP.
DVN DEVON ENERGY CORPORATION
DECK DECKERS OUTDOOR CORPORATION
CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC.
CNO CNO FINANCIAL GROUP INC.
CBU COMMUNITY BANK SYSTEM INC.
BIIB BIOGEN INC.
BC BRUNSWICK CORPORATION
HP HELMERICH & PAYNE INC.
PVH PVH CORP.
TTC TORO COMPANY
HOG HARLEY-DAVIDSON INC.
WGO WINNEBAGO INDUSTRIES INC.
APLS APELLIS PHARMACEUTICALS
PRPL PURPLE INNOVATION
GRWG GROWGENERATION
DCOM DIME COMMUNITY BANCSHARES INC
APA APA CORPORATION
AMR ALPHA METALLURGICAL RESOURCES INC
BBWI BATH & BODY WORKS INC
CIVI CIVITAS RESOURCES INC
BORR BORR DRILLING LTD
MBC_w MASTERBRAND INC
NE NOBLE CORP (NEW)
FTREV FORTREA HOLDINGS INC.
GrowGeneration Partners with Arett Sales to Expand Nationwide Distribu...
GrowGeneration Partners with Arett Sales to Expand Nationwide Distribution of Proprietary Cultivation Brands Collaboration will greatly expand GrowGen’s market reach for organic fertilizers, propagation systems, and sustainable growing media across Arett’s 32-state lawn & garden network DENVER, Aug. 26, 2025 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGen” or the “Company”), the nation’s largest specialty hydroponic and organic gardening retailer, today announced it is expanding its U.S. distribution through a new strategic partnership with Arett Sales, a leading natio...
Daxor Corporation Announces Replay of Nasdaq Closing Bell Ceremony Now...
Daxor Corporation Announces Replay of Nasdaq Closing Bell Ceremony Now Available The celebration marks a major milestone for the patent-pending, next-generation, rapid, compact, and hand-held Daxor BVA™. Oak Ridge, TN, Aug. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces that the official replay of its Nasdaq Closing Bell Ceremony is now available. The ceremony, which took place on August 8, 2025, commemorated the FDA 510(k) clearance for its patent-pending, next-generation, rapid, compact, hand-held, lab-based new Da...
GrowGeneration Reports Second Quarter 2025 Financial Results
GrowGeneration Reports Second Quarter 2025 Financial Results Net Sales of $41.0 million, Up 14.7% Sequentially Proprietary Brand Sales Rise to 32.0% of Cultivation and Gardening Revenue Store Operating Expenses Down 22.9% Year-over-Year DENVER, Aug. 11, 2025 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGeneration,” “GrowGen,” or the “Company”), the nation’s largest specialty hydroponic and organic gardening retailer, today announced financial results for the second quarter of 2025. Second Quarter 2025 Summary(1) Net sales of $41.0 million, up 14.7% quarter-over-quart...
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financ...
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate Update -- Recorded $128.9 Million in Fiscal 2025 Revenue, Meeting Full-Year Guidance; Maintains Commitment to Mid-Term Outlook -- -- Nine New Programs Signed with New Customers During Fiscal 2025, Reflecting Growth into Modalities Beyond the Company's Traditional Area of Strength in Ophthalmic Therapeutics -- -- Improved Efficiency and Productivity Across the Organization -- Conference Call Today at 4:30pm ET CHASKA, Minn., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, In...
Daxor Corporation Receives FDA Clearance for New Rapid, Lightweight, B...
Daxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis System Management Expects High Demand Driven by Speed, Simplicity, and Clinical Precision Oak Ridge, TN, Aug. 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces FDA 510(k) clearance (K251087) for its patent-pending next-generation rapid, compact, hand-held, lab-based Blood Volume Analyzer (BVA). The new Daxor BVA™ device quantifies a patient’s blood volume against patient-specific norms, enabling precise fluid management across a b...
- Jonathan Moreland
SNV SYNOVUS FINANCIAL CORP.
SIGI SELECTIVE INSURANCE GROUP INC.
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
SHBI SHORE BANCSHARES INC.
PNFP PINNACLE FINANCIAL PARTNERS INC.
CHTR CHARTER COMMUNICATIONS INC. CLASS A
CDXS CODEXIS
ARW ARROW ELECTRONICS INC.
PETS PETMED EXPRESS INC.
PLBC PLUMAS BANCORP
CYRX CRYOPORT INC.
FTV FORTIVE CORP.
CMTV COMMUNITY BANCORP INC. VT
LRMR LARIMAR THERAPEUTICS INC
AURX NUO THERAPEUTICS
SIRI INC.
SIRIUS XM HLDGS INC NEW
- Jonathan Moreland
MERC MERCER INTERNATIONAL INC.
CDXS CODEXIS
PETS PETMED EXPRESS INC.
CLRB CELLECTAR BIOSCIENCES
NHF NEXPOINT CREDIT STRATEGIES FUN
CZWI CITIZENS COMMUNITY BANCORP
LOOP LOOP INDUSTRIES
CHMG CHEMUNG FINANCIAL CORP.
FVCB FVCBANKCORP
FGBI FIRST GUARANTY BANCSHARES
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
CMTV COMMUNITY BANCORP INC. VT
DMAC DIAMEDICA THERAPEUTICS INC.
CRDF CARDIFF ONCOLOGY INC
IMRX IMMUNEERING CORP
NSPR INSPIREMD INC
BRCC BRC INC
LEXX LEXARIA BIOSCIENCE CORP
PMNT PERFECT MOMENT LTD.
DMA DESTRA MULTI ALTERNATIVE FUND
NYC NEW YORK CITY REIT
GF INC.
FGEN THE NEW GERMANY FUND
CCIF INC.
CVM FIBROGEN INC.
CARLYLE CREDIT INCOME FUND
CEL-SCI CORPORATION
Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Fina...
Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025 Webcast Scheduled for Thursday, August 7 at 4:30 p.m. Eastern CHASKA, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the fourth quarter and fiscal year 2025 on Thursday, August 7, 2025, after market close. At 4:30 p.m. Eastern Time that day, members of Lifecore’s senior management team will host a webcast ...
GrowGeneration Schedules Second Quarter 2025 Earnings Release Conferen...
GrowGeneration Schedules Second Quarter 2025 Earnings Release Conference Call for August 11, 2025 DENVER, July 30, 2025 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGen” or the “Company”), the nation’s largest specialty retailer of hydroponic and organic gardening products, today announced it will release its financial results for the second quarter ended June 30, 2025, on Monday, August 11, 2025, after market close. The announcement will be followed by a live earnings conference call at 4:30 p.m. ET. To participate in the call, please dial 1-(888)-699-1199 (domestic) ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.